Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10679891rdf:typepubmed:Citationlld:pubmed
pubmed-article:10679891lifeskim:mentionsumls-concept:C0521026lld:lifeskim
pubmed-article:10679891lifeskim:mentionsumls-concept:C0014653lld:lifeskim
pubmed-article:10679891lifeskim:mentionsumls-concept:C0026339lld:lifeskim
pubmed-article:10679891lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:10679891lifeskim:mentionsumls-concept:C0026837lld:lifeskim
pubmed-article:10679891lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:10679891lifeskim:mentionsumls-concept:C0030957lld:lifeskim
pubmed-article:10679891lifeskim:mentionsumls-concept:C0243095lld:lifeskim
pubmed-article:10679891lifeskim:mentionsumls-concept:C0242808lld:lifeskim
pubmed-article:10679891pubmed:issue1lld:pubmed
pubmed-article:10679891pubmed:dateCreated2000-4-27lld:pubmed
pubmed-article:10679891pubmed:abstractTextAntigenic site A of foot-and-mouth disease virus (serotype C) has been reproduced by means of cyclic versions of peptide A15, YTASARGDLAHLTTT, corresponding to residues 136-150 of envelope protein VP1. A structural basis for the design of the cyclic peptides is provided by crystallographic data from complexes between the Fab fragments of anti-site A monoclonal antibodies and A15, in which the bound peptide is folded into a quasi-cyclic pattern. Head-to-tail cyclizations of A15 do not provide peptides of superior antigenicity. Internal disulfide cyclization, however, leads to analogs which are recognized as one to two orders of magnitude better than linear A15 in both ELISA and biosensor experiments. CD and NMR studies show that the best antigen, CTASARGDLAHLTT-Ahx-C (disulfide), is very insensitive to environment-induced conformational change, suggesting that cyclization helps to stabilize a bioactive-like structure.lld:pubmed
pubmed-article:10679891pubmed:languageenglld:pubmed
pubmed-article:10679891pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10679891pubmed:citationSubsetIMlld:pubmed
pubmed-article:10679891pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10679891pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10679891pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10679891pubmed:statusMEDLINElld:pubmed
pubmed-article:10679891pubmed:issn0952-3499lld:pubmed
pubmed-article:10679891pubmed:authorpubmed-author:GiraltEElld:pubmed
pubmed-article:10679891pubmed:authorpubmed-author:DomingoEElld:pubmed
pubmed-article:10679891pubmed:authorpubmed-author:AndresFFlld:pubmed
pubmed-article:10679891pubmed:authorpubmed-author:MayerP FPFlld:pubmed
pubmed-article:10679891pubmed:authorpubmed-author:CamareroJ AJAlld:pubmed
pubmed-article:10679891pubmed:authorpubmed-author:ValeroM LMLlld:pubmed
pubmed-article:10679891pubmed:authorpubmed-author:HaackTTlld:pubmed
pubmed-article:10679891pubmed:copyrightInfoCopyright 2000 John Wiley & Sons, Ltd.lld:pubmed
pubmed-article:10679891pubmed:issnTypePrintlld:pubmed
pubmed-article:10679891pubmed:volume13lld:pubmed
pubmed-article:10679891pubmed:ownerNLMlld:pubmed
pubmed-article:10679891pubmed:authorsCompleteYlld:pubmed
pubmed-article:10679891pubmed:pagination5-13lld:pubmed
pubmed-article:10679891pubmed:dateRevised2000-12-18lld:pubmed
pubmed-article:10679891pubmed:meshHeadingpubmed-meshheading:10679891...lld:pubmed
pubmed-article:10679891pubmed:meshHeadingpubmed-meshheading:10679891...lld:pubmed
pubmed-article:10679891pubmed:meshHeadingpubmed-meshheading:10679891...lld:pubmed
pubmed-article:10679891pubmed:meshHeadingpubmed-meshheading:10679891...lld:pubmed
pubmed-article:10679891pubmed:meshHeadingpubmed-meshheading:10679891...lld:pubmed
pubmed-article:10679891pubmed:meshHeadingpubmed-meshheading:10679891...lld:pubmed
pubmed-article:10679891pubmed:meshHeadingpubmed-meshheading:10679891...lld:pubmed
pubmed-article:10679891pubmed:meshHeadingpubmed-meshheading:10679891...lld:pubmed
pubmed-article:10679891pubmed:meshHeadingpubmed-meshheading:10679891...lld:pubmed
pubmed-article:10679891pubmed:meshHeadingpubmed-meshheading:10679891...lld:pubmed
pubmed-article:10679891pubmed:meshHeadingpubmed-meshheading:10679891...lld:pubmed
pubmed-article:10679891pubmed:meshHeadingpubmed-meshheading:10679891...lld:pubmed
pubmed-article:10679891pubmed:meshHeadingpubmed-meshheading:10679891...lld:pubmed
pubmed-article:10679891pubmed:articleTitleNative-like cyclic peptide models of a viral antigenic site: finding a balance between rigidity and flexibility.lld:pubmed
pubmed-article:10679891pubmed:affiliationDepartament de Química Orgànica, Universitat de Barcelona, Barcelona, Spain.lld:pubmed
pubmed-article:10679891pubmed:publicationTypeJournal Articlelld:pubmed